Jodi Daniel joins Crowell & Moring LLP

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

JODI DANIEL joined the firm Crowell & Moring LLP as a partner in its Health Care Group.

Daniel is the former director of the Office of Policy in the Office of the National Coordinator for Health Information Technology at the Department of Health and Human Services. Daniel served for a decade as the director at the ONC and 15 years at HHS, where she worked on changes in health information privacy and health information technology.

As the first senior counsel for health information technology in the Office of the General Counsel of HHS, Daniel developed HHS’s foundational legal strategies and coordinated all legal advice regarding health IT for HHS.

“Jodi literally wrote the book—and all the rules— governing health information technology, including the complex HIPAA privacy and enforcement rules,” said John Brennan, Jr., chair of the firm’s Health Care Group. “Her experience in setting the regulatory framework and policies for both technology providers and adopters has supported innovation in areas including mobile health, remote devices and telehealth, and that insight will be of enormous value to our clients as they operate in this highly regulated space.”

YOU MAY BE INTERESTED IN

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.
Michael R. Caputo, a cancer survivor and a Republican political operative with a wide-ranging resume, was named to the President’s Cancer Panel, a board formed under the National Cancer Act to monitor the National Cancer Program and report to the president about “barriers to progress in reducing the burden of cancer.”
For over two decades, the ASCO Genitourinary Cancers Symposiumhas stood as the premier global event that has helped advance cancer science and transform care. The 2027 Symposium will continue this legacy from Feb. 11–13 in San Francisco by bringing together the largest international audience in GU oncology to help define tomorrow’s standards of care. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login